Literature DB >> 10636530

Risk stratification of sudden cardiac death and malignant ventricular arrhythmias in right ventricular dysplasia-cardiomyopathy.

S Peters1, H Peters, L Thierfelder.   

Abstract

UNLABELLED: Arrhythmogenic right ventricular dysplasia-cardiomyopathy is in most cases a benign cause of ventricular arrhythmias in young patients. The major reason of mortality is sudden arrhythmic death with an annual rate of 2-3% as the first manifestation of the disease in most cases. Little is known about risk factors of sudden arrhythmic death so far. The purpose of the retrospective study was to classify risk factors from invasive and non-invasive examinations.
METHODS: In a cohort of 121 consecutive patients sampled from 1986 to 1998 the value of right ventricular dilatation, left ventricular involvement analysed by angiocardiography or echocardiography and standard ECG parameters such as precordial T wave inversions, right precordial ST elevation, precordial QRS dispersion, left precordial JT interval prolongation and complete right bundle branch block were determined. The whole cohort of patients were divided into two groups with high arrhythmic risk (aborted or non-aborted sudden death, recurrent ventricular tachycardia despite medical treatment, recurrent syncopes) and low risk (frequent ventricular premature beats, non sustained ventricular tachycardia, uneventful course under medical therapy).
RESULTS: From angiocardiography or echocardiography in a quantitative approach right ventricular dilatation (p<0.0001) and additional left ventricular abnormalities (p<0.0001) could be identified as major risk factors. From an ECG point of view increased precordial QRS dispersion > or =50 ms (p<0.01) with complete right bundle branch block and right ventricular dilatation in most cases and precordial T wave inversions beyond V3 (p<0.0001) and the phenomenon of left precordial JT interval prolongation (JT dispersion > or =30 ms) in cases of additional left ventricular abnormalities represented non-invasive predictors of recurrent arrhythmic events. Right precordial ST segment elevation could be excluded as risk factor of sudden arrhythmic death.
CONCLUSIONS: Right ventricular dilatation with ECG depolarisation abnormalities and additional left ventricular involvement with striking ECG repolarisation abnormalities could be identified as strong risk factors of recurrent arrhythmic events in ARVD with unfavorable prognosis.

Entities:  

Mesh:

Year:  1999        PMID: 10636530     DOI: 10.1016/s0167-5273(99)00142-4

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  19 in total

Review 1.  Clinical interpretation of genetic variants in arrhythmogenic right ventricular cardiomyopathy.

Authors:  Mireia Alcalde; Oscar Campuzano; Georgia Sarquella-Brugada; Elena Arbelo; Catarina Allegue; Sara Partemi; Anna Iglesias; Antonio Oliva; Josep Brugada; Ramon Brugada
Journal:  Clin Res Cardiol       Date:  2014-11-15       Impact factor: 5.460

Review 2.  Long-range silencing and position effects at telomeres and centromeres: parallels and differences.

Authors:  S Perrod; S M Gasser
Journal:  Cell Mol Life Sci       Date:  2003-11       Impact factor: 9.261

Review 3.  Arrhythmogenic right ventricular cardiomyopathy/dysplasia: risk stratification and therapy.

Authors:  Gianfranco Buja; N A Mark Estes; Thomas Wichter; Domenico Corrado; Frank Marcus; Gaetano Thiene
Journal:  Prog Cardiovasc Dis       Date:  2008 Jan-Feb       Impact factor: 8.194

4.  Prognostic implications of QRS dispersion for major adverse cardiovascular events in asymptomatic women and men: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Rahul Jain; Sandeep Gautam; Colin Wu; Changyu Shen; Aditya Jain; Ola Giesdal; Harjit Chahal; Hongbo Lin; David A Bluemke; Elsayed Z Soliman; Saman Nazarian; João A C Lima
Journal:  J Interv Card Electrophysiol       Date:  2019-09-03       Impact factor: 1.900

5.  Long-term follow-up of arrhythmogenic right ventricular cardiomyopathy patients with an implantable cardioverter-defibrillator for prevention of sudden cardiac death.

Authors:  Kang Yin; Ligang Ding; Yuqiu Li; Wei Hua
Journal:  Clin Cardiol       Date:  2017-01-31       Impact factor: 2.882

6.  Diagnosis of arrhythmogenic right ventricular dysplasia-cardiomyopathy: value of standard ECG revisited.

Authors:  Stefan Peters; Martina Trümmel
Journal:  Ann Noninvasive Electrocardiol       Date:  2003-07       Impact factor: 1.468

7.  Predictors of adverse outcome in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy: long term experience of a tertiary care centre.

Authors:  K Lemola; C Brunckhorst; U Helfenstein; E Oechslin; R Jenni; F Duru
Journal:  Heart       Date:  2005-09       Impact factor: 5.994

Review 8.  Noninvasive risk stratification in arrhythmogenic right ventricular cardiomyopathy.

Authors:  Pietro Turrini; Domenico Corrado; Cristina Basso; Andrea Nava; Gaetano Thiene
Journal:  Ann Noninvasive Electrocardiol       Date:  2003-04       Impact factor: 1.468

Review 9.  Arrhythmogenic right ventricular cardiomyopathy: diagnosis and risk stratification.

Authors:  Leif-Hendrik Boldt; Wilhelm Haverkamp
Journal:  Herz       Date:  2009-06       Impact factor: 1.443

Review 10.  [Limits and scopes of invasive risk stratification. Do we still need programmed ventricular stimulation?].

Authors:  Sascha Rolf; Wilhelm Haverkamp
Journal:  Herz       Date:  2009-11       Impact factor: 1.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.